Day: August 6, 2021

iSIGN Media Announces Closing of the First Tranche of its Previously Announced Private Placement of up to $1.2 million for Software Development/Enhancement and Operations

iSIGN Media Announces Closing of the First Tranche of its Previously Announced Private Placement of up to $1.2 million for Software Development/Enhancement and Operations

TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) — iSIGN Media Solutions Inc. (“iSIGN” or “Company”) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that it has closed the first tranche (the “First Tranche”) of its previously announced non-brokered private placement (“Placement”) of up to $1.2 million. The Company completed the First Tranche of the Placement for total gross proceeds of $722,510 by issuing 14,450,200 Units (“Units”) at a price of $0.05 per Unit. Each Unit consists of one Common Share of the Company (each a “Common Share”, collectively, the “Common Shares”) and one common share purchase warrant (each warrant referred to herein as a “Warrant” and collectively, the “Warrants”). Each Warrant entitles the holder to purchase one Common Share...

Continue reading

Questor Announces Passing of Director Jean-Michel Gires

Questor Announces Passing of Director Jean-Michel Gires

CALGARY, Alberta, Aug. 06, 2021 (GLOBE NEWSWIRE) — It is with great sadness that the Board of Directors of Questor Technology Inc. (“Questor” or the “Company”), (TSX Venture Exchange: QST) announce that Jean-Michel Gires, a director, has passed away. “On behalf of the Board of Directors and management at Questor, I wish to extend my deepest condolences to Jean-Michel’s family and friends at this difficult time,” said Audrey Mascarenhas, President and CEO. Jean-Michel had been a Questor director since September 2013. He was truly a visionary leader who cared passionately about making a difference.  Jean-Michel was a tremendous supporter of the Company and his vast industry experience mixed with his passion for the environment was greatly appreciated. Mr. Gires passed away in Germany surrounded...

Continue reading

Brookfield Infrastructure Extends Offer to Purchase Inter Pipeline Ltd. – Revised Offer Open Until August 20th at 5 p.m. (Mountain Time)

Brookfield Infrastructure Extends Offer to Purchase Inter Pipeline Ltd. – Revised Offer Open Until August 20th at 5 p.m. (Mountain Time)

Brookfield Infrastructure has received strong support from Inter Pipeline Ltd. (“IPL”) shareholders to date and reminds IPL shareholders to tender their shares in support of the Offer. Tendering is required in order to receive consideration under the Offer IPL shareholders that have already tendered do not need to take any further action Shareholders may elect up to 100% cash consideration, totalling C$20.00 per share of IPL without being subject to proration or 0.250 of a class A exchangeable subordinated voting share of Brookfield Infrastructure Corporation (a “BIPC Share”), subject to proration Questions or Need Assistance? Contact Laurel Hill Advisory Group at 1-877-452-7184 or email assistance@laurelhill.com BROOKFIELD, NEWS, Aug. 06, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN),...

Continue reading

atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference

atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference

BERLIN, Aug. 06, 2021 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it will participate in a fireside chat and one-on-one investor meetings at the Canaccord Genuity Growth Conference, to be held virtually from August 10-12, 2021. Presentation details can be found below: 41st Annual Canaccord Genuity Growth ConferenceFormat: Fireside chat Date and Time: Tuesday, August 10th, 2:30 p.m. ETWebcast link: https://wsw.com/webcast/canaccord60/atai/2419868 About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental...

Continue reading

Canadian International Trade Tribunal to Maintain Antidumping and Countervailing Duties on Sugar Imports

Canadian International Trade Tribunal to Maintain Antidumping and Countervailing Duties on Sugar Imports

MONTRÉAL and VANCOUVER, British Columbia, Aug. 06, 2021 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (the “Corporation” or “Rogers Sugar”) (TSX: RSI) is pleased to recognize that the Canadian International Trade Tribunal has issued a decision to pursue its orders against dumped and subsidized sugar from the United States (US), the European Union (EU), and the United Kingdom (UK). As a result of this announcement, anti-dumping and countervailing duties will continue to be applied on imported sugar from these regions. “The Tribunal’s decision recognizes that Canadian sugar producers are vulnerable as long as the distortions created by the US, EU, and UK sugar programs continue,” stated Sandra Marsden, President of the Canadian Sugar Institute. “Thus far, global and regional trade negotiations have not resulted in a meaningful change to the...

Continue reading

Logiq Announces Closing of US$4 Million Financing

Logiq Announces Closing of US$4 Million Financing

NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (NEO: LGIQ) (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, announced the closing of a public offering, raising gross proceeds of approximately US$4.0 (C$5.0) million before deducting offering expenses. In connection with the offering, Logiq entered into a Stock Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “Registered Offering”), 1,668,042 shares (the “Shares”) of the Company’s common stock, par value US$0.0001 per share (the “Common Stock”), to the Purchasers at an offering price of US$2.40 (C$3.00) per share. The price for the Registered Offering was reserved with the NEO Exchange on July 16, 2021. Separately,...

Continue reading

IBA - Regulated Information

IBA – Regulated Information

IBA – ACQUISITION OF OWN SHARES Immediate Release – August 6th, 2021 Louvain-la-Neuve, Belgium, August 6th, 2021 – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on June 29th, 2021. Under this program, IBA has requested a financial intermediary to repurchase up to 250.000 IBA ordinary shares on its behalf under the terms of a discretionary mandate agreement with validity until December 30th, 2021, effective as from June 30th, 2021, to cover the company’s obligations under a long term incentive plan for certain members of its personnel. In the framework of this share buyback program, IBA repurchased 7.655 IBA shares on Euronext Brussels in the...

Continue reading

SEB Announces Amended Omnibus Long Term Incentive Plan and Grant of Stock Options and RSUs

SEB Announces Amended Omnibus Long Term Incentive Plan and Grant of Stock Options and RSUs

MISSISSAUGA, Ontario, Aug. 06, 2021 (GLOBE NEWSWIRE) — Smart Employee Benefits Inc. (“SEB” or the “Company”) (TSXV: SEB) announces that the proposed amendments to the Company’s Omnibus Long-Term Incentive Plan (the “Plan”) were approved by shareholders at the annual meeting of shareholders held on May 27, 2021, and which amendments were set out in the Company’s management information circular for the meeting. Certain additional housekeeping and clerical amendments are currently being incorporated into the Plan, subject to approval from TSX Venture Exchange (the “Exchange”). Upon receipt of Exchange approval, a copy of the further amended Plan will be available on SEDAR under the Company’s profile at www.sedar.com. The Company also wishes to announce that its Board of Directors has approved the following grants pursuant to the Company’s...

Continue reading

BioVie Inc. Announces Proposed Public Offering of Common Stock

BioVie Inc. Announces Proposed Public Offering of Common Stock

SANTA MONICA, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders, liver disease and certain cancers, today announced that it intends to offer shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. ThinkEquity, a division of Fordham Financial Management, Inc., is acting as the sole book-running manager for the offering. EF Hutton, division of Benchmark Investments, LLC, is acting as a financial advisor for the offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the...

Continue reading

The Flowr Corporation Announces Appointment to the Board of Directors

The Flowr Corporation Announces Appointment to the Board of Directors

TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) — The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce that Ryan Roebuck has joined the Board of Directors of the Company effective immediately. Mr. Roebuck is the co-founder and CEO of Edition X, which owns and operates cannabis retail stores and branded products and accessories in Canada and California. Prior to Edition X, for seven years, Mr. Roebuck was a partner at XDL Capital, managing a portfolio of early-stage investments with a focus on the cannabis sector. Over the time at XDL Capital, dozens of investments were made into the sector since 2012 with numerous realized exits. Mr. Roebuck was previously a founding director and investor of Pharmacan Capital (now Cronos Group Inc.) and began his career as a top-rated equity research analyst...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.